Moxifloxacin Impurity N39 CAS 1824286-08-9
| CAS No. | 1824286-08-9 |
| Molecular Formula | C9H7ClF2O3 |
| Molecular Weight | 236.60 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
As a certified reference material (CRM), Moxifloxacin Impurity N39 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
CATO supplies Moxifloxacin Impurity N39 (CAS 1824286-08-9), a pharmacopoeial impurity reference standard (molecular formula C9H7ClF2O3, MW 236.60 g/mol) used for the identification and quantification of trace impurities in APIs.
Structurally, Moxifloxacin Impurity N39 (C9H7ClF2O3) contains a carboxylic acid group, a hydroxyl group, an ether linkage, fluorine/chlorine substitution, an aromatic ring system. The molecule exhibits a degree of unsaturation (DBE) of 5.0, corresponding to approximately 5 ring(s) or double-bond equivalent(s). With a molecular weight of 236.60 g/mol, it falls into the medium-molecular-weight range. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
Physical & Chemical Properties
| Molecular Formula | C9H7ClF2O3 |
| Molecular Weight | 236.60 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store in a cool place (≤25°C), keep sealed and dry, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in methanol, ethanol, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 5.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1995 |
| Halogen Content | F/Cl-containing |
Related Moxifloxacin Standards
- Moxifloxacin Impurity 16 (CAS 28749-88-4)
- Moxifloxacin Impurity 70 (CAS 133492-64-5)
- Moxifloxacin Impurity 114 (CAS 652-03-9)
- Moxifloxacin Impurity 64 (CAS 18184-75-3)
- Moxifloxacin Impurity N41 (CAS 172602-81-2)
- Moxifloxacin impurity 160 (CAS 1415319-29-7)
- Moxifloxacin Impurity 95 (CAS 71083-22-2)
- Moxifloxacin Impurity 55 (CAS 53764-99-1)
Recommended Standards
- Methyl 4-chloro-2-(difluoromethoxy)benzoate (CAS 639826-30-5)
- 2-(4-Chloro-5-cyano-pyrrolo[2,3-d]pyrimidin-7-yl)acetic acid (CAS 2122273-77-0)
- Methyl 2-chloro-4-(difluoromethoxy)benzoate (CAS 97914-56-2)
- 2-Chloro-4-(3-nitrophenyl)-1,3,5-triazine (CAS 919085-47-5)
- Crisaborole impurity 113 (CAS CATO-C4X-2021113)
- Dorzolamide EP Impurity A (CAS 120279-95-0)
- Halometasone Impurity N2 (CAS 80157-55-7)
- Methyl 3-((2,4-dichlorobenzyl)oxy)thiophene-2-carboxylate (CAS 343375-78-0)
- For-met-leu-phe-ome (CAS 65929-03-5)
- 2-Chloro-n-[2-(3-chlorophenyl)ethyl]acetamide (CAS 34162-15-7)
- 2-(Isoquinolin-5-yl)-3-methylbutanoic acid (CAS 1486905-58-1)
- 2-(Difluoromethyl)-4-iodo-3-methylpyridine-6-sulfonyl chloride (CAS 1806982-62-6)
- 1-[(2R,3S)-4-[(4-Chloro-1,1,2,2,3,3,4,4-octafluorobutyl)sulfonyl]-5-methyl-3-(4-nitrophenyl)-2,3-dihydro-2-furanyl]ethanone (CAS 771491-74-8)
- Palmitoyl Tripeptide -5 · 2 TFA (CAS 623172-56-5)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com